Abstract
Triterpenoid alkaloids are one of the most important classes that have been studied. Buxus alkaloids are such a type of triterpenoid alkaloids of cycloartenol skeleton with a degraded C-20 side chain, and with the nitrogen containing substituents at C-3 and/or C-20. 219 Buxus alkaloids have been reported so far. This review article focuses on the structural characters, plant sources and biological activities of Buxus alkaloids. This review includes anti-myocardial ischemia, inhibition of acetyl- and butyryl-cholinesterases, cytotoxicity and antibacterial activities. The biological activities, mechanisms and structure modifications of cyclovirobuxine D (CVB-D) are also described.
Keywords: Buxaceae, Buxus alkaloid, cyclovirobuxine D, structure modification, biological activity, triterpenoid alkaloids, plant sources, antibacterial, herbal medicine, anti-myocardial ischemia
Current Bioactive Compounds
Title: Chemistry and Biological Activities of Buxus Alkaloids
Volume: 7 Issue: 1
Author(s): Yu-Xin Yan, Yun Sun, Zhong-Rong Li, Lin Zhou and Ming-Hua Qiu
Affiliation:
Keywords: Buxaceae, Buxus alkaloid, cyclovirobuxine D, structure modification, biological activity, triterpenoid alkaloids, plant sources, antibacterial, herbal medicine, anti-myocardial ischemia
Abstract: Triterpenoid alkaloids are one of the most important classes that have been studied. Buxus alkaloids are such a type of triterpenoid alkaloids of cycloartenol skeleton with a degraded C-20 side chain, and with the nitrogen containing substituents at C-3 and/or C-20. 219 Buxus alkaloids have been reported so far. This review article focuses on the structural characters, plant sources and biological activities of Buxus alkaloids. This review includes anti-myocardial ischemia, inhibition of acetyl- and butyryl-cholinesterases, cytotoxicity and antibacterial activities. The biological activities, mechanisms and structure modifications of cyclovirobuxine D (CVB-D) are also described.
Export Options
About this article
Cite this article as:
Yan Yu-Xin, Sun Yun, Li Zhong-Rong, Zhou Lin and Qiu Ming-Hua, Chemistry and Biological Activities of Buxus Alkaloids, Current Bioactive Compounds 2011; 7 (1) . https://dx.doi.org/10.2174/157340711795163811
DOI https://dx.doi.org/10.2174/157340711795163811 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Imaging Aided Improvement in Drug Discovery and Development
Current Biotechnology FK506 and Its Analogs - Therapeutic Potential for Neurological Disorders
Current Drug Targets - CNS & Neurological Disorders Endocannabinoids in Liver Disease and Hepatic Encephalopathy
Current Pharmaceutical Design Hypertension in Hemodialysis Patients
Current Hypertension Reviews 1α ,25(OH)2-Vitamin D3 and 17β-Estradiol: Two Steroid Partners Acting in Skeletal Muscle
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury
Current Drug Targets Substance P and its Inhibition in Ocular Inflammation
Current Drug Targets Emerging Role for Antioxidant Therapy in Protection Against Diabetic Cardiac Complications: Experimental and Clinical Evidence for Utilization of Classic and New Antioxidants
Current Cardiology Reviews Hematopoietic Colony Stimulating Factors in Cardiovascular and Pulmonary Remodeling: Promoters or Inhibitors?
Current Pharmaceutical Design Expression of the Two Pore Domain Potassium Channel TREK-1 in Human Intervertebral Disc Cells
Current Stem Cell Research & Therapy Review on Patents for Ubiquitin-Proteasome Inhibitor as Medical Advance in Major Human Diseases
Recent Patents on Biomedical Engineering (Discontinued) Cellular Therapy for Heart Failure
Current Cardiology Reviews Safety of Cabergoline in the Management of Pituitary Prolactin-Induced Symptoms with Patients Treated with Atypical Neuroleptics
Current Drug Safety Fluoride Interactions: From Molecules to Disease
Current Signal Transduction Therapy Cell Therapy for Inner Ear Diseases
Current Pharmaceutical Design The Second Generation of COX-2 Inhibitors: Clinical Pharmacological Point of View
Mini-Reviews in Medicinal Chemistry P2X Receptors in the Cardiovascular System and their Potential as Therapeutic Targets in Disease
Current Medicinal Chemistry The Pivotal Role of Nitric Oxide: Effects on the Nervous and Immune Systems
Current Pharmaceutical Design ALDH2---The Genetic Polymorphism and Enzymatic Activity Regulation: Their Epidemiologic and Clinical Implications
Current Drug Targets Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug
Inflammation & Allergy - Drug Targets (Discontinued)